All Articles

The Tumor Board/AKA: The MDC
By Penny Daugherty, RN, OCN, ONN-CG; Margaret Rummel, RN, MHA, OCN, NE-BC
October 2020 Vol 11, No 10
Presenting the concept of the tumor board to your patient and acting as their representative.
Read More
Immunotherapy Doubles Progression-Free Survival in Advanced Colorectal Cancer Subset
Colorectal Cancer
October 2020 Vol 11, No 10
There’s a new standard of care in the first-line setting for a subset of patients with advanced colorectal cancer.
Read More
Patient Support Services in Multiple Myeloma
IWTI 2020 Video Series
Patient Support Services in Multiple Myeloma
By Charise Gleason, MSN, NP-BC, AOCNP; Chelsea Sprouse, RN-BSN, MSN, NP-C; Kathryn Maples, PharmD, BCOP
Interview with the Innovators
Video Library
Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, discuss their personal experiences with patient support groups for multiple myeloma patients that deal with pharmacy issues, financial problems, management of pain and neuropathy, psychological and nutritional support.
Read More
This Just In: AONN+ Certifications Are Now Nationally Accredited!
By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Letters from Lillie
September 2020 Vol 11, No 9
Congratulations to AONN+ FFL for earning ANAB national accreditation for the Oncology Nurse Navigator–Certified Generalist (ONN-CG) and the Oncology Patient Navigator–Certified Generalist (OPN-CG) certifications.
Read More
Checkpoint Inhibitors
By Faith A. Mutale, MSN, CRNP; Cecile Miller, MSN, CRNP
Immunotherapy
September 2020 Vol 11, No 9
Historically, surgery, chemotherapy, and radiation have been the mainstay of most cancer therapies. Although these modalities have been successful and improved survival outcomes, cancer remains one of the most debilitating diagnoses, often with poor outcomes.
Read More
Cancer Death Rate Decline Should Not Be Lost in Current Climate
By Amy Jo Pixley, MSN, RN, OCN, ONN-CG(T)
Lung Cancer
September 2020 Vol 11, No 9
The decline in mortality from lung cancer has gone from 2% per year to 4% overall. Here’s how we’ve accomplished the decline.
Read More

Page 142 of 281

Journal of Oncology Navigation & Survivorship

Contact Us | Editorial Board

Amplity

© Amplity, Inc. All rights reserved.

Connect with Us

 
 
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country

Back to Top

Amplity © Amplity, Inc. All rights reserved.